secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0000950170-22-014467
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q2 adjusted EPS $0.47 vs $0.41 YoY; revenue up 2.7%; FY22 EBITDA outlook reaffirmed
--------------------------------------------------------------------------------

- GAAP EPS $0.36 flat YoY; adjusted EPS $0.47 vs $0.41 on revenue of $486M (+2.7%).
- Same-unit revenue down 1.3%; volume up 0.6% offset by reimbursement decline of 1.9%.
- Adjusted EBITDA flat at $65.6M; FY22 outlook reaffirmed at $260-270M.
- Repurchased 3.3M shares for $64.4M in Q2; total debt $800M after refinancing.
- Interest expense fell to $8.4M from $16.9M due to Q1 refinancing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017022014467/0000950170-22-014467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017022014467/md-20220804.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-014467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer